Clinical Trial Update: YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for YAZ in China assessing post-authorization safety and efficacy in contraception.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• YAZ (DROSPIRENONE AND ETHINYL ESTRADIOL)

Snippet

Sponsor: Bayer | Conditions: Contraception | Phase 4 | Status: COMPLETED